Zhi Wang (PhD candidate)
Academic Health Sciences Research Fellow, Wang Lab
Department of Urology

Title:  “ELL2 modulation of prostate cancer proliferation, apoptosis and viability is regulated by Birc3 (cIAP2) via interaction with p53”

and

Zeyu [Brian] Wu (MD candidate)
Central South University
Xiangya School of Medicine
Visiting Scholar, Wang Lab
Department of Urology
 

Title:  “Compound 450 can inhibit MDV 3100 resistant AR mutant F876L function in vivo and in vitro”